Tgf-beta receptor type 1 kinase domain (t204d) in complex with 6-[1-(2,2-difluoroethyl)-4-(6-methylpyridin-2-yl)-1h-imidazol-5-yl]imidazo[1,2-a]pyridine Deposition Author(s): Sheriff, S.
Date: 2019-11-19 Method: X-RAY DIFFRACTION Resolution: 1.83 Å Organism(s): Homo Sapiens Sequences Data: 5QTZ_A
Tgf-beta receptor type 1 kinase domain (t204d) in complex with 6-[4-(3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1h-imidazol-5-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Deposition Author(s): Sheriff, S.
Date: 2019-11-19 Method: X-RAY DIFFRACTION Resolution: 1.67 Å Organism(s): Homo Sapiens Sequences Data: 5QU0_A
Crystal structure of the human brd2 bd1 bromodomain in complex with 9-(cyclopropylmethyl)-7-[(2r,6s)-2,6-dimethylmorpholine-4-carbonyl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)-9h-carbazole-1-carboxamide Deposition Author(s): Sheriff, S.
Date: 2021-04-01 Method: X-RAY DIFFRACTION Resolution: 2.49 Å Organism(s): Homo Sapiens Sequences Data: 5S9O_A , 5S9O_B
Crystal structure of the first bromodomain of human brd4 in complex with 9-benzyl-2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9h-carbazole-4-carboxamide Deposition Author(s): Sheriff, S.
Date: 2021-04-01 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 5S9P_A , 5S9P_B , 5S9P_D , 5S9P_E
Crystal structure of the first bromodomain of human brd4 in complex with 2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9-[(s)-(oxan-4-yl)(phenyl)methyl]-9h-carbazole-4-carboxamide Deposition Author(s): Sheriff, S.
Date: 2021-04-01 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 5S9Q_A , 5S9Q_B , 5S9Q_D , 5S9Q_E
Crystal structure of the first bromodomain of human brd4 in complex with bms-986158, 2-{3-(1,4-dimethyl-1h-1,2,3-triazol-5-yl)-5-[(s)-(oxan-4-yl)(phenyl)methyl]-5h-pyrido[3,2-b]indol-7-yl}propan-2-ol Deposition Author(s): Sheriff, S.
Date: 2021-04-01 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 5S9R_A
Factor xia in complex with the inhibitor ((15s)-18-chloro- 15-(((2e)-3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2- propenoyl)amino)-17,19-diazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,16(19)-pentaen-5-yl)carbamate Deposition Author(s): Sheriff, S.
Date: 2016-10-07 Method: X-RAY DIFFRACTION Resolution: 1.55 Å Organism(s): Homo Sapiens Sequences Data: 5TKS_A
Factor xia in complex with the inhibitor methyl ((12e,15s)-15-(((2e)-3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2-propenoyl)amino)-9-oxo-8,17,19-triazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,12,16(19)-hexaen-5-yl)carbamate Deposition Author(s): Sheriff, S.
Date: 2016-10-07 Method: X-RAY DIFFRACTION Resolution: 2.12 Å Organism(s): Homo Sapiens Sequences Data: 5TKT_A
Factor xia in complex with the inhibitor methyl ((15s)-15-(((2e)-3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2-propenoyl)amino)-9-oxo-8,17,19-triazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,16(19)-pentaen-5-yl)carbamate Deposition Author(s): Sheriff, S.
Date: 2016-10-07 Method: X-RAY DIFFRACTION Resolution: 2.12 Å Organism(s): Homo Sapiens Sequences Data: 5TKU_A
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase in complex with 2-[(benzenecarbonyl)amino]-3-[(4-chlorophenyl)methoxy]benzoic acid Deposition Author(s): Sheriff, S.
Date: 2016-10-26 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Hepatitis C Virus Sequences Data: 5TRH_A , 5TRH_B